Cytokinetics market cap
As of November 2026, Cytokinetics (CYTK) has a market capitalization of $7.15 B, which makes it #1131 among the world’s largest public companies. Over the past year its value changed by −24.5%.
Market cap$7.15 B
World rank#1131
1 year−24.5%
Share price$51.46
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $7.15 B | −19.0% |
| 2025 | $8.83 B | +35.1% |
| 2024 | $6.54 B | −43.7% |
| 2023 | $11.60 B | +82.2% |
| 2022 | $6.37 B | +0.53% |
| 2021 | $6.33 B | +119% |
| 2020 | $2.89 B | +95.9% |
| 2019 | $1.47 B | +67.9% |
| 2018 | $878.00 M | −22.5% |
| 2017 | $1.13 B | −32.9% |
| 2016 | $1.69 B | +16.2% |
| 2015 | $1.45 B | +30.6% |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.